4. Final Judgment:
FURTHER ORDERED that judgment on priority as to Count 2, the sole count in
the interference, is awarded against junior party Glaxo Wellcome, Inc.;
FURTHER ORDERED that junior party Glaxo Wellcome, Inc., is not entitled to
a patent containing claims 1-7 of patent 5,545,403 which correspond to proposed Count 2;
FURTHER ORDERED that junior party Glaxo Wellcome, Inc., is not entitled to
a patent containing claims 1-7 of patent 5,545,404 which correspond to proposed Count 2;
FURTHER ORDERED that junior party Glaxo Wellcome, Inc., is not entitled to
a patent containing claims 1-9 of patent 5,545,405 which correspond to proposed Count 2;
FURTHER ORDERED that a copy of this decision be given a paper number and
be entered in the administrative records of Glaxo’s 5,545,403, 5,545,404, and 5,545,405 patents
and Cabilly’s 08/909,611 application;
-56-
Page: Previous 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 Next
Last modified: November 3, 2007